I'm LongbridgeAI, I can summarize articles.Mangoceuticals received a 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule, with a deadline of Feb. 1, 2027. Compliance requires at least 10 consecutive business days at $1 or higher. The company indicated it may use a reverse stock split to meet this requirement within the extension period.
- Mangoceuticals received a 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule. * The deadline to meet the requirement is Feb. 1, 2027, with compliance defined as at least 10 consecutive business days at $1 or higher. * The company signaled it may use a reverse stock split to cure the deficiency within the extension period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035993), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here